INC Research Holdings Inc
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with… Read more
INC Research Holdings Inc (INCR) - Total Assets
Latest total assets as of June 2025: $751.76 Million USD
Based on the latest financial reports, INC Research Holdings Inc (INCR) holds total assets worth $751.76 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
INC Research Holdings Inc - Total Assets Trend (2011–2024)
This chart illustrates how INC Research Holdings Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
INC Research Holdings Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
INC Research Holdings Inc's total assets of $751.76 Million consist of 51.4% current assets and 48.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 10.3% |
| Accounts Receivable | $180.50 Million | 23.7% |
| Inventory | $125.33 Million | 16.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $224.59 Million | 29.5% |
Asset Composition Trend (2011–2024)
This chart illustrates how INC Research Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: INC Research Holdings Inc's current assets represent 51.4% of total assets in 2024, a decrease from 90.1% in 2011.
- Cash Position: Cash and equivalents constituted 10.3% of total assets in 2024, down from 39.9% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 29.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 29.5% of total assets.
INC Research Holdings Inc Competitors by Total Assets
Key competitors of INC Research Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp Preferred
KO:000105
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
|
Yuyu Pharma
KO:000220
|
Korea | ₩202.42 Billion |
|
Ildong Holdings Co Ltd
KO:000230
|
Korea | ₩813.62 Billion |
INC Research Holdings Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - INC Research Holdings Inc generates 0.31x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - INC Research Holdings Inc is currently not profitable relative to its asset base.
INC Research Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.85 | 1.78 | 1.15 |
| Quick Ratio | 1.12 | 1.15 | 0.87 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $172.03 Million | $ 161.94 Million | $ 6.07 Million |
INC Research Holdings Inc - Advanced Valuation Insights
This section examines the relationship between INC Research Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.32 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -3.1% |
| Total Assets | $762.57 Million |
| Market Capitalization | $30.08 Million USD |
Valuation Analysis
Below Book Valuation: The market values INC Research Holdings Inc's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: INC Research Holdings Inc's assets decreased by 3.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for INC Research Holdings Inc (2011–2024)
The table below shows the annual total assets of INC Research Holdings Inc from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $762.57 Million | -3.06% |
| 2023-12-31 | $786.61 Million | -17.89% |
| 2022-12-31 | $958.01 Million | +39.59% |
| 2021-12-31 | $686.32 Million | +110.35% |
| 2020-12-31 | $326.27 Million | +15.60% |
| 2019-12-31 | $282.23 Million | +685.73% |
| 2018-12-31 | $35.92 Million | +50.00% |
| 2017-12-31 | $23.95 Million | -13.66% |
| 2016-12-31 | $27.73 Million | +119.75% |
| 2015-12-31 | $12.62 Million | +378.04% |
| 2014-12-31 | $2.64 Million | -57.17% |
| 2013-12-31 | $6.16 Million | -57.57% |
| 2012-12-31 | $14.53 Million | +397.71% |
| 2011-12-31 | $2.92 Million | -- |